Seeing Is Believing
Currently out of the existing stock ratings of Maury Raycroft, 83 are a BUY (79.81%), 21 are a HOLD (20.19%).
Analyst Maury Raycroft works at JEFFERIES with a stock forecast success ratio of 49.03% fulfilled within 134.48 days on average.
Maury Raycroft’s has documented 226 price targets and ratings displayed on 33 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on BCRX, BioCryst Pharmaceuticals at 03-Nov-2023.
Analyst best performing recommendations are on VERA (VERA THERAPEUTICS).
The best stock recommendation documented was for ALNY (ALNYLAM PHARMACEUTICALS) at 9/18/2017. The price target of $102 was fulfilled within 2 days with a profit of $26 (34.21%) receiving and performance score of 171.05.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
5
$-1.33 (-21.01%)
1
18 days ago
2/4 (50%)
$-1.35 (-21.26%)
42
Buy
18 days ago
0/2 (0%)
$7.45 (163.74%)
Buy
10
$3.67 (57.98%)
18 days ago
1/2 (50%)
$3.65 (57.48%)
452
Buy
25
$18.67 (294.94%)
18 days ago
0/1 (0%)
$18.65 (293.70%)
Buy
8 months 8 days ago
0/2 (0%)
$5.19 (76.21%)
Which stock is Maury Raycroft is most bullish on?
What Year was the first public recommendation made by Maury Raycroft?